ATK Biotech

Based in China, ATK Biotech is a developer of specialized functional food ingredients, focused on supporting infant nutrition and health through innovative products derived from algae oil and other essential compounds. ATK Biotech, founded in 2018 in Chuzhou, China, is engaged in the production of functional food ingredients. The company has successfully completed one deal to date, and their most recent funding round occurred on January 30, 2026. Anhui Tiankai Biotechnology Co.

, Ltd. specializes in producing functional food ingredients, including DHA algae oil and ARA oil, which are essential for cognitive function and eye health in infants and children. The company plans to introduce OPO oil and functional whey protein, enhancing fatty acids and calcium absorption. Their offerings cater to infant nutrition manufacturers, dietary supplement producers, and specialized medical food developers, emphasizing strict quality standards and eco-friendly practices across domestic and international markets.

Anhui Tiankai Biotechnology Co. , Ltd. operates on a B2B revenue model by partnering with manufacturers and distributors in the food and supplement industries. Their flagship products, such as DHA and ARA oils, are sold in bulk to clients who incorporate them into various formulations, supporting a diverse client portfolio that includes both large brands and niche producers.

In January 2026, ATK Biotech secured venture funding from Hongchuang Capital and Shanghai Xuanbao Enterprise Development Co. , Ltd. to support their upcoming product launches, including OPO oil and functional whey protein. The company aims to expand its market reach into new geographic regions over the next few years, focusing on both domestic and international markets to enhance their distribution capabilities.